Corris Paul A
Institute of Cellular Medicine, Newcastle University and Freeman Hospital, United Kingdom, NE7 7DN.
Semin Respir Crit Care Med. 2009 Aug;30(4):493-501. doi: 10.1055/s-0029-1233318. Epub 2009 Jul 24.
The development of specific disease-targeted therapy for pulmonary arterial hypertension has offered a major advancement in the management of patients, and these medical treatments have been shown to improve both quality and quantity of life. Nevertheless, many patients deteriorate with time and will require consideration of other approaches. This article focuses on the roles of atrial septostomy and lung transplantation.
针对肺动脉高压的特异性疾病靶向治疗的发展为患者管理带来了重大进展，并且这些医学治疗已被证明可改善生活质量和延长生存期。然而，许多患者会随着时间推移而病情恶化，需要考虑其他治疗方法。本文重点关注房间隔造口术和肺移植的作用。
